atazanavir sulfate has been researched along with nitazoxanide in 2 studies
Studies (atazanavir sulfate) | Trials (atazanavir sulfate) | Recent Studies (post-2010) (atazanavir sulfate) | Studies (nitazoxanide) | Trials (nitazoxanide) | Recent Studies (post-2010) (nitazoxanide) |
---|---|---|---|---|---|
1,102 | 246 | 590 | 573 | 85 | 352 |
Protein | Taxonomy | atazanavir sulfate (IC50) | nitazoxanide (IC50) |
---|---|---|---|
Aldo-keto reductase family 1 member B1 | Homo sapiens (human) | 8.22 | |
Signal transducer and activator of transcription 3 | Homo sapiens (human) | 9.89 | |
Anoctamin-1 | Homo sapiens (human) | 0.424 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 2 (100.00) | 2.80 |
Authors | Studies |
---|---|
Adeagbo, BA; Adebiyi, AO; Adefuye, BO; Akinloye, A; Bolaji, OO; Fagbamigbe, AF; Fowotade, A; Happi, C; Ladipo, OT; Ojo, TO; Olagunju, A; Olagunju, OI; Olagunoye, A; Onayade, A; Owen, A; Rannard, S | 1 |
Tsanni, A | 1 |
1 trial(s) available for atazanavir sulfate and nitazoxanide
Article | Year |
---|---|
Efficacy and safety of nitazoxanide plus atazanavir/ritonavir for the treatment of moderate to severe COVID-19 (NACOVID): A structured summary of a study protocol for a randomised controlled trial.
Topics: Administration, Oral; Adolescent; Adult; Aged; Antiviral Agents; Atazanavir Sulfate; Clinical Trials, Phase II as Topic; COVID-19; COVID-19 Drug Treatment; COVID-19 Nucleic Acid Testing; Drug Administration Schedule; Drug Combinations; Drug Repositioning; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Multicenter Studies as Topic; Nigeria; Nitro Compounds; Pilot Projects; Randomized Controlled Trials as Topic; Ritonavir; RNA, Viral; SARS-CoV-2; Severity of Illness Index; Standard of Care; Thiazoles; Treatment Outcome; Viral Load; Young Adult | 2021 |
1 other study(ies) available for atazanavir sulfate and nitazoxanide
Article | Year |
---|---|
African scientists race to test COVID drugs - but face major hurdles.
Topics: Africa; Amides; Amodiaquine; Artesunate; Atazanavir Sulfate; Carbamates; Clinical Trials as Topic; COVID-19; COVID-19 Drug Treatment; COVID-19 Vaccines; Cytidine; Drug Approval; Drug Evaluation, Preclinical; Drug Repositioning; Drug Therapy, Combination; Humans; Hydroxylamines; Imidazoles; Ivermectin; Naphthyridines; Nitro Compounds; Pregnenediones; Pyrazines; Pyrrolidines; Ritonavir; Sample Size; Thiazoles; Valine; World Health Organization | 2021 |